FXN and Friedreich ataxia: As indicated by our study, the molecular transitions facilitated by FXN occur at low efficiency in the absence of this protein, and may serve as the basis for the development of small molecules mimicking FXN function for therapeutic regimes of Friedreich’s ataxia.